GSK Cleared By FIPB To Increase Stake In India Unit To 75%
This article was originally published in PharmAsia News
Executive Summary
India authorities have cleared GlaxoSmithKline's bid to increase the company's stake in one of its subsidiaries by nearly one-fourth to give the UK-based company a 75% interest.